Search Results

Filter
  • 1-10 of  141 results for ""Heparan Sulfate Proteoglycans""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.

  • Authors : Crespo A; Department of Biotechnology, Neiker-Tecnalia Arkaute, 01080, Vitoria-Gasteiz, Spain.; García-Suárez O

Subjects: Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*pathology ; Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/*genetics; Aged

  • Source: BMC cancer [BMC Cancer] 2018 Jun 25; Vol. 18 (1), pp. 687. Date of Electronic Publication: 2018 Jun 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.

Subjects: Gene Expression Regulation, Neoplastic*; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*genetics ; Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/*genetics

  • Source: BMC cancer [BMC Cancer] 2015 Oct 20; Vol. 15, pp. 742. Date of Electronic Publication: 2015 Oct 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.

  • Authors : Fernández-Vega I; Department of Pathology, Hospital Universitario Central de Asturias, Oviedo 33006, Spain.; García O

Subjects: Gene Expression Regulation, Enzymologic* ; Gene Expression Regulation, Neoplastic*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics

  • Source: BMC cancer [BMC Cancer] 2013 Jan 17; Vol. 13, pp. 24. Date of Electronic Publication: 2013 Jan 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.

  • Authors : Connor JP; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Wisconsin School of Medicine and Public Health, Madison, WI 53703, USA. ; Felder M

Subjects: Gene Expression Regulation, Neoplastic*/Gene Expression Regulation, Neoplastic*/Gene Expression Regulation, Neoplastic*/drug effects ; Genes, BRCA1*; Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/Heparan Sulfate Proteoglycans/*metabolism

  • Source: BMC cancer [BMC Cancer] 2012 May 14; Vol. 12, pp. 176. Date of Electronic Publication: 2012 May 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Heparan sulfate mediates trastuzumab effect in breast cancer cells.

Subjects: *HEPARAN sulfate; *BREAST cancer research; *HER2 protein

  • Source: BMC Cancer. 2013, Vol. 13 Issue 1, p1-13. 13p. 2 Color Photographs, 1 Diagram, 1 Chart, 6 Graphs.

Record details

×
Academic Journal

Heparan sulfate mediates trastuzumab effect in breast cancer cells.

  • Authors : Suarez ER; Department of Biochemistry, Universidade Federal de São Paulo, Rua Três de Maio, 100, Vila Clementino, 04044-020, São Paulo, SP, Brazil. .; Paredes-Gamero EJ

Subjects: Drug Resistance, Neoplasm*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*pharmacology ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology

  • Source: BMC cancer [BMC Cancer] 2013 Oct 01; Vol. 13, pp. 444. Date of Electronic Publication: 2013 Oct 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

  • Authors : Fadnes B; Department of Medical Biochemistry, Institute of Medical Biology, University of Tromsø, Tromsø, Norway. ; Rekdal O

Subjects: Heparitin Sulfate/Heparitin Sulfate/Heparitin Sulfate/*metabolism ; Lactoferrin/Lactoferrin/Lactoferrin/*antagonists & inhibitors ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: BMC cancer [BMC Cancer] 2009 Jun 15; Vol. 9, pp. 183. Date of Electronic Publication: 2009 Jun 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
  • 1-10 of  141 results for ""Heparan Sulfate Proteoglycans""